Bangladesh vs Sri Lanka: Treatment success rate for patients treated for MDR-TB
Bangladesh
78.0%
in 2022
Sri Lanka
79.0%
in 2022
Bangladesh rank
59th
Sri Lanka rank
56th
Treatment success rate for patients treated for MDR-TB over time
- Bangladesh
- Sri Lanka
How they compare
Sri Lanka currently reports 79.0% against 78.0% in Bangladesh, a difference of 1.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Bangladesh ahead.
Bangladesh ranks 59th and Sri Lanka ranks 56th of 163 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Bangladesh | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 29.3% | 46.7% | Bangladesh |
| 2010s | 74.1% | 75.6% | 1.5% | Sri Lanka |
| 2020s | 76.0% | 56.0% | 20.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bangladesh or Sri Lanka?
- Sri Lanka, at 79.0% against 78.0% in Bangladesh as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bangladesh and Sri Lanka?
- 1.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Bangladesh and Sri Lanka?
- 16 years are reported by both, from 2007 to 2022.
- How do Bangladesh and Sri Lanka rank globally for treatment success rate for patients treated for mdr-tb?
- Bangladesh ranks 59th and Sri Lanka ranks 56th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.